Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

Grants for experimental cancer surgery in Denmark in 2017/20

The pool for the provision of experimental cancer surgery is one of the initiatives in Cancer Plan IV and is funded by the Danish Finance Act for 10 million DKK for the period of 2017 - 2020. Experimental treatment covers treatment without same degree of scientific evidence as in standard treatment, if there is likehood that the patient will benefit from experimental treatment.

The first distribution took place in autumn 2017. The second round of applications lasts until September 5, 2018, when interested hospital departments in the Danish regions again apply for funds to perform the experimental surgery.

At the first round of applications in 2017, the National Board of Health distributed approximately 1.7 million DKK for 2017 and about 1.5 million DKK for 2018.

More detailed description of experimental cancer surgery and the process of application can be found here.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

Tags
Denmark

The latest related news

28
Jun 2024

A regular update of the Danish SKS coding system from July 2024

The Danish Health Data Authority quarterly updates the Health Care Classification System (SKS). The updated version was published in mid-June 2024 to come into force on July 1, 2024. Six new surgical procedure codes, twenty new medical procedure codes, and nine new codes for diagnostic investigations were introduced concerning multiple areas, including diagnostic imaging, gastrointestinal, gynecology, orthopedics, and surgical procedures.
Read more
22
May 2024

Expected reassessments of national clinical recommendations in Denmark

The Danish Health Authority has initiated a process of assessing the national clinical recommendations. Work is set to start in 2024. Recommendations in diagnostic imaging, endoscopy, endocrine, ENT, gastrointestinal, nephrology and urology, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, ophthalmology, orthopedics, pulmonary and airways, radiotherapy, spine, and some other fields are considered for reassessment.
Read more
01
May 2024

Preparations for the establishment of the Board for Health Apps in Denmark

The Ministry of the Interior and Health is currently working on the establishment of the Board for Health Apps (Nævnet for sundhedsapps). It is expected that the Board's purpose will be to assess whether the health apps can be recommended to citizens and healthcare professionals in Denmark. The Executive order on the rules of procedure of the Board for Health Apps is expected to enter into force on July 1, 2024, and the Board is foreseen to meet as soon as possible after this.
Read more
24
Apr 2024

New Health Service Quality Institute will be established by 2025 in Denmark

In April 2024, Danish Regions announced the initiative to establish a new organization called the Health Service Quality Institute (Sundhedsvæsnets Kvalitetsinstitut). This initiative is part of the wider Region’s ambitions to develop a new model of working with quality and prioritization in the Danish healthcare system. The new institute is expected to open at the beginning of 2025.
Read more